MATTHEW HEARD: Open Payments
NPI 1720553027 · MONTROSE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Regeneron Healthcare Solutions, Inc. | 1 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Pulmonx Corporation | 1 | $19 |
Products named: FASENRA, WINREVAIR, NUCALA, CHARTIS CATHETER.
Industry payments across CO — which companies pay providers there.
